Mutual Funds
Nippon India Pharma Fund - Growth
OVERVIEW FUND INFO PORTFOLIO

Morningstar Rating™
Not Rated

Morningstar® Category
India OE Specialty - Health		 Total Net Assets (mil)
71,316.64 INR
Morningstar® Benchmark
S&P BSE Healthcare PR
Used throughout report
 Fund Benchmark
S&P BSE Healthcare TR INR


TRAILING RETURNS (%) FUND BENCHMARK CATEGORY
3M 11.58 11.82 11.93
6M 18.46 20.00 18.46
1Y 57.72 58.85 56.07
3Y* 19.34 18.97 17.54
5Y* 22.75 19.20 22.26
10Y* 17.18 12.84 16.21
*Annualised Return Data Through 15/03/2024
QUARTERLY RETURNS (%) Q1 Q2 Q3 Q4
2024 - - - -
2023 -4.25 17.10 11.23 11.58
2022 -7.50 -10.12 8.20 0.15
2021 -1.15 22.06 0.73 1.97
2020 -5.70 31.59 19.50 12.24
2019 1.48 -6.51 -1.11 8.38
RISK MEASURES
3Y Alpha 2.30
3Y Beta 0.96
3Y R-Squared 97.77
3Y Info Ratio 0.87
3Y Tracking Error 2.41
3Y Sharpe Ratio 0.98
3Y Std Dev 15.49
3Y Risk -
5Y Risk -
10Y Risk -
Calculations use S&P BSE Healthcare PR (where applicable)

Morningstar Style BoxTM


* Report as of 18 Mar 2024


© 2024 Morningstar. All Rights Reserved.

Disclaimer :
© 2024 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised;(3) do not constitute investment advice;(4) are provided solely for informational purposes; (5) are not warranted to be complete, accurate or timely; and (6) may be drawn from fund data published on various dates. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.